Recenti progressi in medicina最新文献_第3页

[Long term survival in patient with metastatic breast cancer treated with sacituzmab govitecan.] [转移性乳腺癌患者接受sacituzmab govitecan治疗后的长期生存率]

Recenti progressi in medicina Pub Date : 2024-10-01 DOI: 10.1701/4357.43484

Carlo Mulas, Luigi Mascia

引用次数: 0

Dalla letteratura
2024 Ottobre. 摘自文献 2024 年 10 月。

Recenti progressi in medicina Pub Date : 2024-10-01 DOI: 10.1701/4357.43459

引用次数: 0

[Intra-patient cancer heterogeneity and sacituzumab-govitecan efficacy.] [患者内部癌症异质性与Sacituzumab-Govitecan疗效]

Recenti progressi in medicina Pub Date : 2024-10-01 DOI: 10.1701/4357.43480

Andrea Fontana, Federica Pantaleo

引用次数: 0

[Clinical management of a patient with non-triple-negative breast cancer who converts to a triple-negative subtype at recurrence.] [非三阴性乳腺癌患者在复发时转变为三阴性亚型的临床治疗]。

Recenti progressi in medicina Pub Date : 2024-10-01 DOI: 10.1701/4357.43481

Francesca Poggio

引用次数: 0

Recensioni.
“Il primo libro di sociologia della salute”. 评论："第一本关于健康社会学的书"。

Recenti progressi in medicina Pub Date : 2024-10-01 DOI: 10.1701/4357.43473

引用次数: 0

Sacituzumab govitecan nel trattamento delle pazienti anziane con carcinoma mammario metastatico. 萨妥珠单抗戈维替康治疗老年转移性乳腺癌患者。

Recenti progressi in medicina Pub Date : 2024-10-01 DOI: 10.1701/4357.43482

Marta Perachino, Matteo Lambertini

引用次数: 0

Twelve tips for medical teachers to facilitate effective discussion among students to engage in reflective interpretation of Museum Arts [医学教师促进学生有效讨论以参与博物馆艺术反思性阐释的十二条建议]。

Recenti progressi in medicina Pub Date : 2024-10-01 DOI: 10.1701/4357.43463

Krishna Mohan Surapaneni

{"title":"Twelve tips for medical teachers to facilitate effective discussion among students to engage in reflective interpretation of Museum Arts","authors":"Krishna Mohan Surapaneni","doi":"10.1701/4357.43463","DOIUrl":"10.1701/4357.43463","url":null,"abstract":"Integrating arts and humanities into medical education is a pragmatic approach that significantly enriches students’ learning experiences by enhancing their observational, interpretative, and empathetic skills. Engaging students in thoughtful dialogue become crucial at it not only enriches their understanding of human experiences and cultural contexts but also sharpens their communication skills – essential for effective patient interactions and collaborative healthcare environments. This article outlines twelve essential tips for medical teachers aimed at effectively facilitating discussions among students within the context of museum arts. These strategies are carefully designed to create a safe and inclusive learning environment, promote active and equitable participation, and encourage deep, reflective interpretation of artworks. By implementing these tips, educators can not only foster a more conducive educational landscape but also significantly enhance their own teaching practices by pushing the boundaries of traditional medical curricula with new ways to integrate empathy, critical thinking, and cultural awareness.","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142506780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Efficacy of topical tirbanibulin in treating grade 2 actinic keratosis.] [外用替巴尼布林治疗 2 级光化性角化病的疗效]。

Recenti progressi in medicina Pub Date : 2024-10-01 DOI: 10.1701/4357.43477

Alessia Villani

{"title":"[Efficacy of topical tirbanibulin in treating grade 2 actinic keratosis.]","authors":"Alessia Villani","doi":"10.1701/4357.43477","DOIUrl":"10.1701/4357.43477","url":null,"abstract":"Actinic keratoses (AK) are common precancerous lesions usually arising on chronic sun-exposed areas. Field of cancerization (FC) is a chronically UV-exposed area in which subclinical multifocal AKs are found. Therapeutic choice is mainly made according to the Olsen grade of AKs. We report the case of a 76-year-old man with numerous AKs of the face and scalp. The patient had undergone numerous topical physical and medical therapies with poor results. On the left cheek, grade I and grade II AKs were found in a large FC, so he was prescribed topical therapy with tirbanibulin 1% ointment. After 10 days erythema and crusts were objectified and a burning sensation was reported on the area of application and on surrounding areas. At 8 weeks follow-up, the patient had total resolution of disease and no residual local side effects. Although tirbanibulin 1% ointment has indication for type I AKs of face and scalp, this case reported its efficacy and benefit also on type II AKs, demonstrating safety and a minimal and manageable degree of discomfort caused to the patient. Therefore, it fits fully among the treatments of grade I AKs but numerous still may be its indications as demonstrated in our case, where efficacy, safety and compliance were combined.","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142506782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Ritratto di Luciano Orsi: al servizio delle persone malate. 卢西亚诺-奥尔西（Luciano Orsi）肖像：为病人服务。

Recenti progressi in medicina Pub Date : 2024-09-01 DOI: 10.1701/4334.43187

引用次数: 0

[Anticoagulant therapy in venous thromboembolism and bleeding risk: focus on the use of predictive scores.] [静脉血栓栓塞症的抗凝治疗与出血风险：重点关注预测评分的使用。］

Recenti progressi in medicina Pub Date : 2024-09-01 DOI: 10.1701/4334.43177

Laura M Cavagna, Mario Bazzan

{"title":"[Anticoagulant therapy in venous thromboembolism and bleeding risk: focus on the use of predictive scores.]","authors":"Laura M Cavagna, Mario Bazzan","doi":"10.1701/4334.43177","DOIUrl":"https://doi.org/10.1701/4334.43177","url":null,"abstract":"The standard treatment for venous thromboembolism (Vte) is anticoagulation. Drug selection and treatment duration will depend on the clinical presentation, the existence of provoking factors, bleeding risk, and the patient's preferences. Anticoagulation therapy is indicated for 3-6 months in all patients with acute Vte but may be extended, even indefinitely in some cases. The most severe side effect of anticoagulation is bleeding, with the highest risk occurring during the 1st months of therapy. Balancing the risk of bleeding and the risk of recurrence in patients with Vte remain a major issue. There are, currently, no simple and validated predictive scores to estimate the long-term bleeding risk in patients undergoing anticoagulant treatment and to safely select those patients with higher bleeding risk. In this review we will examine some of these scores, including the RIETE scores, the HAS-BLED SCORE, the VTE-BLEED score, the VTE- PREDICT and the ACCP guidelines and the timing for their application in the patient's population treated for Vte as well as the initial and long-term management and evaluation of thromboembolic disease.","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0